-links colocalize using the pathological lesions in Alzheimer’s illness brain. Brain Pathol. 2009, 19, 612?22. Dorval, V.; Fraser P.E. Compact ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J. Biol. Chem. 2006, 281, 9919?924. Cripps, D.; Thomas, S.N.; Jeng, Y.; Yang, F.; Davies, P.; Yang, A.J. Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated by means of Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J. Biol. Chem. 2006, 281, 10825?0838. Mondrag -Rodr uez, S.; Basurto-Islas, G.; Binder, L.I.; Garc -Sierra, F. Conformational modifications and cleavage; are these accountable for the tau aggregation in Alzheimer’s illness? Futur. Neurol. 2009, four, 39?three.Int. J. Mol. Sci. 2014, 15 74.75.76. 77.78.79.80.81.82.83.84.85.86.Bhat, R.V.; Shanley, J.; Correll, M.P.; Fieles, W.E.; Keith, R.A.; Scott, C.W.; Lee, C.M. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. USA 2000, 26, 11074?1079. Wang, Q.M.; Fiol, C.J.; DePaoli-Roach, A.A.; Roach, P.J. Glycogen synthase kinase-3 beta can be a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 1994, 269, 14566?4574. Giese, K.P. GSK-3: A important player in neurodegeneration and memory. IUBMB Life 2009, 61, 516?21. Ishiguro, K.; Shiratsuchi, A.; Sato, S.; Omori, A.; Arioka, M.; Kobayashi, S.; Uchida, T.; Imahori, K. Glycogen synthase kinase three beta is identical to tau protein kinase I creating numerous epitopes of paired helical filaments. FEBS Lett. 1993, 325, 167?72. Lovestone, S.; Reynolds, C.H.; Latimer, D.; Davis, D.R.; Anderton, B.H.; Gallo, J.M.; Hanger, D.; Mulot, S.; Marquardt, B.; Stabel, S.; et al. Alzheimer disease-like phosphorylation in the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.Formula of 1233717-68-4 Curr.1-(2-Ethynylphenyl)ethanone web Biol.PMID:33612706 1994, four, 1077?086. Reynolds, C.H.; Betts, J.C.; Blackstock, W.P.; Nebreda, A.R.; Anderton, B.H. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Variations in vitro involving the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 2000, 74, 1587?595. Pei, J.J.; Tanaka, T.; Tung, Y.C.; Braak, E.; Iqbal, K.; Grundke-Iqbal, I. Distribution, levels, and activity of glycogen synthase kinase-3 within the Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 1997, 56, 70?eight. Leroy, K.; Boutajangout, A.; Authelet, M.; Woodgett, J.R.; Anderton, B.H.; Brion, J.P. The active form of glycogen synthase kinase-3 is connected with granulovacuolar degeneration in neurons in Alzheimers’s disease. Acta Neuropathol. 2002, 103, 91?9. Yamaguchi, H.; Ishiguro, K.; Uchida, T.; Takashima, A.; Lemere, C.A.; Imahori, K. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a element of TPK II. Acta Neuropathol. 1996, 92, 232?41. Alvarez, G.; Munoz-Montano, J.R.; Satrustegui, J.; Avila, J.; Bogonez, E.; Diaz-Nido, J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett. 1999, 453, 260?64. Tan, W.F.; Cao, X.Z.; Wang, J.K.; Lv, H.W.; Wu, B.Y. Protective effects of lithium remedy for spatial memory deficits induced by tau hyperphosphorylation in splenectomized.